Catharina Willemien M. V. D. H. V. O.
- Country
- The Netherlands
- Department
- Medical Oncology
Research Overview
- Evaluation of Safety, Tolerability, and PET Imaging Effects of GEH200520 and GEH200521 (18F) in Patients with Irresectable or Metastatic Solid Tumors
- Evaluation of BI 764532 Uptake in Tumors of Patients with Large Cell Neuroendocrine Lung Carcinoma, Neuroendocrine Carcinoma, or Small Cell Lung Carcinoma
- Evaluation of Tumor Microenvironment Alterations Following Intradermal Ipilimumab and Intravenous Nivolumab Combination Therapy in Patients with Unresectable Stage III-IV Melanoma
Data & Insights
Has run more than one trial at 38 of 224 partner sites.
Specializations
Oncology Focus
This investigator specializes in treating diverse advanced solid tumors, with particular emphasis on head and neck cancer and head and neck squamous cell carcinoma.
- Advanced Cancer Management
- Head and Neck Oncology
- Solid Tumor Therapeutics
The investigator explores novel therapeutic approaches for advanced cancer treatment.
Specialized Cancer Areas
Demonstrates expertise in treating neuroendocrine tumors and breast cancer, with focus on ER+/HER2- breast cancer cases.
- Neuroendocrine Tumor Treatment
- Breast Cancer Management
- Hormone Receptor-Positive Disease
Actively involved in evaluating treatment responses and disease progression monitoring.
Additional Expertise
Shows proficiency in treating non-small cell lung cancer and melanoma, implementing various therapeutic strategies.
- Lung Cancer Treatment
- Melanoma Management
- Advanced Cancer Therapeutics
Engages in evaluation of novel treatment combinations and therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.